RIPE-KG · Version 1.1.0 · Resource

ripekg:study-design-evidence/RIPEA22B2228793442254

https://w3id.org/ripe/ripe-kg/study-design-evidence/RIPEA22B2228793442254
SubjectPredicateObject
ripekg:evaluation/RIPEA22B2228793442254 prov:used ripekg:study-design-evidence/RIPEA22B2228793442254
ripekg:study-design-evidence/RIPEA22B2228793442254 rdf:type rdfs:Resource
ripekg:study-design-evidence/RIPEA22B2228793442254 rdf:type owl:Thing
ripekg:study-design-evidence/RIPEA22B2228793442254 rdf:type ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence
ripekg:study-design-evidence/RIPEA22B2228793442254 rdf:type ripe:StudyDesignEvidenceStudy design evidence
ripekg:study-design-evidence/RIPEA22B2228793442254 rdf:type tido:Evidence
ripekg:study-design-evidence/RIPEA22B2228793442254 prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA22B2228793442254
ripekg:study-design-evidence/RIPEA22B2228793442254 prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA22B2228793442254
ripekg:study-design-evidence/RIPEA22B2228793442254 ripe:concerns ripekg:work/10.1016%2Fj.clnu.2014.09.015Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome
ripekg:study-design-evidence/RIPEA22B2228793442254 ripe:recruitmentEndDate 12-2013
ripekg:study-design-evidence/RIPEA22B2228793442254 ripe:recruitmentEndDateExtractionRationale Methods: 'This randomized double-blind placebo controlled clinical trial was performed in Kashan, Iran, during September 2013 to December 2013.'
ripekg:study-design-evidence/RIPEA22B2228793442254 ripe:recruitmentStartDate 09-2013
ripekg:study-design-evidence/RIPEA22B2228793442254 ripe:recruitmentStartDateExtractionRationale Methods: 'This randomized double-blind placebo controlled clinical trial was performed in Kashan, Iran, during September 2013 to December 2013.'
ripekg:study-design-evidence/RIPEA22B2228793442254 ripe:studyEndDateExtractionRationale No explicit study completion date found.
ripekg:study-design-evidence/RIPEA22B2228793442254 tido:supports ripekg:integrity-assessment-hypothesis/RIPEA22B2228793442254-human-2-2
ripekg:study-design-evidence/RIPEA22B2228793442254 tido:supports ripekg:integrity-assessment-hypothesis/RIPEA22B2228793442254-inspectai-2-2